1677 - In vitro Activity of SPR206 and Comparator Compounds against Enterobacterales Isolates Responsible for Infections in United States Hospitals

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Helio S. Sader, MD, PhD

Senior Director, Microbiology & Surveillance
JMI Laboratories
North Liberty, Iowa, United States
SA

SJ Ryan Arends, PhD

Principal Scientist
JMI Laboratories
North Liberty, Iowa, United States
NC

Nicole Cotroneo, BS

Director
Spero Therapeutics
Boston, Massachusetts, United States
Ian A. Critchley, PhD

Vice President, Head
Spero Therapeutics
Cambridge, Massachusetts, United States
Mariana Castanheira, PhD

Chief Scientific Officer
JMI Laboratories
North Liberty, Iowa, United States